
LifeStance Health Group, Inc.
LifeStance Health Group, Inc. (LFST) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
lfst · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for LifeStance Health Group, Inc. (LFST) measures how much investors pay for each dollar of the company's trailing earnings. LFST's current PE ratio of 123.86x is calculated by dividing its stock price of $7.36 by its TTM earnings per share of $0.06. −85.6% discount vs 5Y avg 862.3x
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2019 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Medical - Care Facilities · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
LifeStance Health Group, Inc.You LFST | $2.9B | 123.86x | +442.9% | $0.06 |
Acadia Healthcare Company, Inc. ACHC | $2.3B | N/A | — | -$12.16 |
Addus HomeCare Corporation ADUS | $1.7B | 20.66x | -9.5% | $5.20 |
Ardent Health Partners, LLC ARDT | $1.2B | 9.15x | -59.9% | $0.96 |
Astrana Health, Inc. ASTH | $1.9B | 54.15x | +137.3% | $0.46 |
Aveanna Healthcare Holdings Inc. AVAH | $1.4B | 7.31x | -68.0% | $1.11 |
Brookdale Senior Living Inc. BKD | $2.8B | N/A | — | -$1.12 |
Industry Average 4 peers with valid PE | — | 22.82x | baseline | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | 281.23x | $0.03 | — | |
2024-12-31 FY2024 | — | $-0.15 | — | |
2023-12-31 FY2023 | — | $-0.51 | — | |
2022-12-31 FY2022 | — | $-0.61 | — | |
2021-12-31 FY2021 | — | $-0.94 | — | |
2020-12-31 FY2020 | — | $-0.10 | — | |
2019-12-31 FY2019 | 1443.45x | $0.02 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for LifeStance Health Group, Inc. (LFST) measures how much investors pay for each dollar of the company's trailing earnings. LFST's current PE ratio of 123.86x is calculated by dividing its stock price of $7.36 by its TTM earnings per share of $0.06.
Frequently asked questions
LFST pe ratio · 6 questionsLFST's current PE ratio is 123.86x as of 2026-06-08, based on a stock price of $7.36 and TTM EPS of $0.06. Data sourced from Financial Modeling Prep via LFST's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · LifeStance Health Group, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08